Unani Herbal Treatment for High Cholesterol

Clinical Efficacy of Ithrifal Muqil in Management of Dasumath-e-Dam (Dyslipidaemia)-A Non-Randomized Single Arm Clinical Trail - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/06/088541

Enrollment

Registered

2025-06-10

Start date

Unknown

Completion date

Unknown

Last updated

2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E785- Hyperlipidemia, unspecified

Interventions

Intervention1: Ithrifal Muqil: 10grams twice a day after food water orally FOR 21 DAYS MINIMUM TO 45 DAYS MAXIMUM. If the symptoms totally subsides, it will be stopped in 21 days, or else it will be

Eligibility

Inclusion criteria

Inclusion criteria: Patients with abnormal lipid profile, obesity, known case of diabetesand hypothyroidism.

Exclusion criteria

Exclusion criteria: Patients below 25 years, above 60 years, Disease like AIDS , malignancies, pregnancy and lactation

Design outcomes

Primary

Measure	Time frame
Expecting lipid profile levels return to normal range and improvement in quality of living.Timepoint: 15 days , 30 days and 45 days after starting therapy.	—

Secondary

Measure	Time frame
Expecting no immediate adverse effectsTimepoint: 15 days , 30 days and 45 days after starting therapy.	—

Countries

India

Contacts

Public ContactDrMubasheera Begum

Government Unani Medical College, Chennai

muskaan.m@gmail.com9841620486

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026